Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hyundai ADM Bio Inc. (187660:KRX), powered by AI.
Hyundai ADM Bio Inc. is currently trading at ₩9,770. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hyundai ADM Bio Inc. on Alpha Lenz.
Hyundai ADM Bio Inc.'s P/E ratio is -36.5.
“Hyundai ADM Bio Inc. trades at a P/E of -36.5 (undervalued) with modest ROE of -104.6%.”
Ask for details →Hyundai ADM Bio Inc. operates within the biotechnology sector, focusing on the development and production of advanced biomaterials. The primary purpose of the company is to innovate and manufacture sustainable and eco-friendly materials that can be utilized across various industries, including medical, agricultural, and consumer goods. One of the notable features of Hyundai ADM Bio Inc. is its emphasis on integrating biotechnology with traditional material science to create products that meet modern environmental standards. By leveraging cutting-edge research and development, the company aims to provide solutions that contribute to a more sustainable future. Hyundai ADM Bio Inc.'s operations significantly impact sectors such as health care, where biocompatible materials are essential, and agriculture, where biodegradable products can enhance sustainability. Its role in the market is critical as it addresses the growing demand for environmentally-friendly alternatives in material manufacturing, thereby supporting industries in reducing their carbon footprint and improving ecological balance.
“Hyundai ADM Bio Inc. trades at a P/E of -36.5 (undervalued) with modest ROE of -104.6%.”
Ask for details →Hyundai ADM Bio Inc. (ticker: 187660) is a company listed on KRX in the Healthcare sector (Medical Care Facilities). It has approximately 160 employees. Market cap is $541.9B.
The current price is ₩9,770 with a P/E ratio of -36.54x and P/B of 25.17x.
ROE is -104.62% and operating margin is -79.55%. Annual revenue is $9.3B.